Clinical Trial Update: Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis [Phase 1]

View source ↗

Summary

A Phase 1 study to assess safety, tolerability, and pharmacokinetics of ATTO-3712 in healthy volunteers and subjects with atopic dermatitis; the trial is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ATTO-3712

Snippet

Sponsor: Attovia Therapeutics Inc | Conditions: Normal Volunteers, Atopic Dermatitis (AD) | Phase 1 | Status: RECRUITING